Please login to the form below

Not currently logged in
Email:
Password:

Editas Medicine adds to its board of directors

Jessica Hopfield will also serve on the genome editing firm's audit committee

Jessica HopfieldGenome editing company Editas Medicine has strengthened its board of directors with the addition of Jessica Hopfield, who will also serve on the board's audit committee.

She said: “I am honoured to join Editas Medicine’s board of directors.

Editas is on the forefront of a new era in medicine, and I look forward to working with the team and helping guide the company in the coming years.”

Dr Hopfield has more than two decades worth of experience in the medical and healthcare fields and she has held management positions at Merck Sharp & Dohme (MSD) in clinical development, outcomes research and marketing.

Katrine Bosley, president and chief executive officer of Editas Medicine, said: “With her wide range of scientific and business expertise, Jessica brings great strategic acumen to Editas Medicine, and I am pleased to welcome her to our board of directors.

“Her contributions as a director on our board will be vital as work towards achieving our long-range goals for the year 2022 and vision for advancing Editas Medicine as a leading genome editing company.”

22nd February 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics